loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Elobixibat

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Elobixibat

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 5,289Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Another blow to NASH,disappointing trial results spell end for darkhorse Albireo
    Another blow to NASH,disappointing trial results spell end for darkhorse Albireo

    20 Aug 2020

    // Jason Mast ENDPTS

    https://endpts.com/another-blow-to-nash-disappointing-trial-results-spell-end-for-darkhorse-player-albireo/

    Jason Mast ENDPTS
    20 Aug 2020
    Share Share
    Albireo Reports Topline Results from Phase 2 Trial of Elobixibat in NAFLD/NASH
    Albireo Reports Topline Results from Phase 2 Trial of Elobixibat in NAFLD/NASH

    18 Aug 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/08/18/2080294/0/en/Albireo-Reports-Topline-Results-from-Phase-2-Trial-of-Elobixibat-in-NAFLD-NASH.html

    GLOBENEWSWIRE
    18 Aug 2020
    Share Share